Literature DB >> 26687186

Attenuating Ischemic Disruption of K+ Homeostasis in the Cortex of Hypoxic-Ischemic Neonatal Rats: DOR Activation vs. Acupuncture Treatment.

Dongman Chao1, Qinyu Wang1, Gianfranco Balboni2, Guanghong Ding3,4, Ying Xia5.   

Abstract

Perinatal hypoxic-ischemic (HI) brain injury results in death or profound long-term neurologic disability in both children and adults. However, there is no effective pharmacological therapy due to a poor understanding of HI events, especially the initial triggers for hypoxic-ischemic injury such as disrupted ionic homeostasis and the lack of effective intervention strategy. In the present study, we showed that neonatal brains undergo a developmental increase in the disruption of K+ homeostasis during simulated ischemia, oxygen-glucose deprivation (OGD) and neonatal HI cortex has a triple phasic response (earlier attenuation, later enhancement, and then recovery) of disrupted K+ homeostasis to OGD. This response partially involves the activity of the δ-opioid receptor (DOR) since the earlier attenuation of ischemic disruption of K+ homeostasis could be blocked by DOR antagonism, while the later enhancement was reversed by DOR activation. Similar to DOR activation, acupuncture, a strategy to promote DOR activity, could partially reverse the later enhanced ischemic disruption of K+ homeostasis in the neonatal cortex. Since maintaining cellular K+ homeostasis and inhibiting excessive K+ fluxes in the early phase of hypoxic-ischemic insults may be of therapeutic benefit in the treatment of ischemic brain injury and related neurodegenerative conditions, and since many neurons and other cells can be rescued during the "window of opportunity" after HI insults, our first findings regarding the role of acupuncture and DOR in attenuating ischemic disruption of K+ homeostasis in the neonatal HI brain suggest a potential intervention therapy in the treatment of neonatal brain injury, especially hypoxic-ischemic encephalopathy.

Entities:  

Keywords:  Acupuncture; Cortex; K+ homeostasis; Neonatal hypoxia-ischemia; Neuroprotection; δ-opioid receptor

Mesh:

Substances:

Year:  2015        PMID: 26687186     DOI: 10.1007/s12035-015-9621-4

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  61 in total

1.  Major difference in the expression of delta- and mu-opioid receptors between turtle and rat brain.

Authors:  Y Xia; G G Haddad
Journal:  J Comp Neurol       Date:  2001-07-23       Impact factor: 3.215

2.  Multiple opiate receptors. Enkephalins and morphine bind to receptors of different specificity.

Authors:  K J Chang; P Cuatrecasas
Journal:  J Biol Chem       Date:  1979-04-25       Impact factor: 5.157

3.  Developmental changes in potassium currents at the rat calyx of Held presynaptic terminal.

Authors:  Yukihiro Nakamura; Tomoyuki Takahashi
Journal:  J Physiol       Date:  2007-03-01       Impact factor: 5.182

4.  Expression of potassium channels during postnatal differentiation of rabbit Müller glial cells.

Authors:  A Bringmann; B Biedermann; A Reichenbach
Journal:  Eur J Neurosci       Date:  1999-08       Impact factor: 3.386

5.  Chemokine and inflammatory cell response to hypoxia-ischemia in immature rats.

Authors:  E Bona; A L Andersson; K Blomgren; E Gilland; M Puka-Sundvall; K Gustafson; H Hagberg
Journal:  Pediatr Res       Date:  1999-04       Impact factor: 3.756

6.  Postnatal development of voltage-sensitive Na+ channels in rat brain.

Authors:  Y Xia; G G Haddad
Journal:  J Comp Neurol       Date:  1994-07-08       Impact factor: 3.215

7.  Neurochemical changes following occlusion of the middle cerebral artery in rats.

Authors:  G V Allen; R T Cheung; D F Cechetto
Journal:  Neuroscience       Date:  1995-10       Impact factor: 3.590

8.  White matter axon vulnerability to AMPA/kainate receptor-mediated ischemic injury is developmentally regulated.

Authors:  William J McCarran; Mark P Goldberg
Journal:  J Neurosci       Date:  2007-04-11       Impact factor: 6.167

Review 9.  Perinatal hypoxic-ischemic encephalopathy.

Authors:  Ming-Chi Lai; San-Nan Yang
Journal:  J Biomed Biotechnol       Date:  2010-12-13

10.  Delayed brain ischemia tolerance induced by electroacupuncture pretreatment is mediated via MCP-induced protein 1.

Authors:  Zhuqing Jin; Jian Liang; Jing Wang; Pappachan E Kolattukudy
Journal:  J Neuroinflammation       Date:  2013-05-10       Impact factor: 8.322

View more
  6 in total

Review 1.  Delta Opioids: Neuroprotective Roles in Preclinical Studies.

Authors:  Shahid Husain
Journal:  J Ocul Pharmacol Ther       Date:  2018 Jan/Feb       Impact factor: 2.671

2.  A Critical Role of δ-Opioid Receptor in Anti-microglial Activation Under Stress.

Authors:  Yuan Xu; Feng Zhi; Ya Peng; Jiahao Mao; Gianfranco Balboni; Yilin Yang; Ying Xia
Journal:  Front Aging Neurosci       Date:  2022-05-19       Impact factor: 5.702

Review 3.  Current Tracking on Effectiveness and Mechanisms of Acupuncture Therapy: A Literature Review of High-Quality Studies.

Authors:  Fu-Ming Yang; Lin Yao; Shen-Jun Wang; Yi Guo; Zhi-Fang Xu; Chien-Hung Zhang; Kuo Zhang; Yu-Xin Fang; Yang-Yang Liu
Journal:  Chin J Integr Med       Date:  2019-02-01       Impact factor: 1.978

4.  Condition-specific transcriptional regulation of neuronal ion channel genes in brain ischemia.

Authors:  Luisa Hernandez-Encarnacion; Pankaj Sharma; Roger Simon; An Zhou
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2017-12-25

5.  Elevated OPRD1 promoter methylation in Alzheimer's disease patients.

Authors:  Huihui Ji; Yunliang Wang; Guili Liu; Lan Chang; Zhongming Chen; Dongsheng Zhou; Xuting Xu; Wei Cui; Qingxiao Hong; Liting Jiang; Jinfeng Li; Xiaohui Zhou; Ying Li; Zhiping Guo; Qin Zha; Yanfang Niu; Qiuyan Weng; Shiwei Duan; Qinwen Wang
Journal:  PLoS One       Date:  2017-03-02       Impact factor: 3.240

6.  Identification and Validation of Immune Cells and Hub Genes in Gastric Cancer Microenvironment.

Authors:  Huan Wang; Jianfang Rong; Qiaoyun Zhao; Conghua Song; Rulin Zhao; Sihai Chen; Yong Xie
Journal:  Dis Markers       Date:  2022-04-05       Impact factor: 3.434

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.